Announcements Trials

Browse Landscape

Phase

Status

Sponsor Class

Study Type

Interventional 1

Sponsor

Cancer Type

Conditions

Prostatic Neoplasms 2 Castration Resistant Metastatic Prostate Cancer 2 Uterine Cervical Neoplasms 1 Neoplasms 1 Multiple Endocrine Neoplasia Type 1 1 Fatigue 1 Castration-resistant Prostate Cancer 1 Castration-Resistant Prostate Carcinoma 1 Carcinoma, Squamous Cell 1 Cachexia 1

Interventions

Fulvestrant 5 Exercise 5 Eating 5 Standard of Care 3 Sodium Chloride 3 Diet 3 Alpelisib 3 ribociclib 2 gallium Ga 68 dotatate 2 exemestane 2 Vitamin D 2 Tamoxifen 2 Magnetic Resonance Spectroscopy 2 Letrozole 2 Ethanol 2 Blood Specimen Collection 2 Anastrozole 2 zopiclone 1 ziprasidone 1 veliparib 1 testosterone undecanoate 1 testosterone enanthate 1 pazopanib 1 mirabegron 1 methyl hydroxyethyl cellulose 1 lenvatinib 1 fluorocholine 1 evolocumab 1 dimethandrolone-undecanoate 1 cyclopropapyrroloindole 1

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

Clinical Trials

1 trials

Recent Start date Enrollment

Multiple Endocrine Neoplasia Type 1 × testosterone enanthate × Clear all

NCT00493987 2010-05-13

5aR

Eunice Kennedy Shriver National Institute of Child Health and Human Development (NICHD)

Phase 4 Completed

Multiple Endocrine Neoplasia Type 1

Data powered by HemOnc (CC BY 4.0) Colophon ⚡